HOPE brings hope for the use of the ankle-brachial index as cardiovascular risk marker

European Heart Journal

Volumn 25, Issue 1, 2004, Pages 1-2

  Duprez, Daniel ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL;

ANGIOCARDIOGRAPHY; ANKLE BRACHIAL INDEX; ARTERY DISEASE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DOPPLER FLOWMETRY; EDITORIAL; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; ULTRASOUND;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANKLE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; HUMANS; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER;

EID: 0346727586     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.08.006     Document Type: Editorial

References (6)

1. Ostergren JB, Sleight P, Dagenais G et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J 2004;25:17-24.
2. Hirsch AT, Criqui MH, Treat-Jacobson D et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24.
3. Leng GC, Fowkes FG, Lee AJ et al. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 1996; 313:1440-4.
4. Newman AB, Shemanski L, Manolio TA et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the cardiovascular health study. Arterioscler Thromb Vasc Biol 1999;19:538-45.
5. Duprez DA, De Buyzere M, De Bruyne L et al. Small and large artery elasticity indices in peripheral arterial occlusive disease (PAOD). Vasc Med 2001;6:211-4.
6. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk for ischaemic events. Lancet 1996;345:615-8.